Revange Nutrition Happy Bee 60 caps - GIGACULT

Product guide · Restricted substance

Revange Nutrition Happy Bee 60 caps

Revange Nutrition

Stimulant formula from Revange Nutrition, 60 capsules. This guide sets out what the manufacturer states about the composition of Revange Nutrition Happy Bee 60 caps, what independent research says about its main ingredients, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.

Educational guide · Sources checked 4 November 2026 · 16 references

Back to the product
Named ingredients
9
Amounts stated
None
Status
Restricted substance
Evidence summaries
9

Overview

Manufacturer information

Ingredients & composition

Manufacturer information
IngredientAmount
NoopeptNot stated
PhenylpiracetamNot stated
DMHANot stated
5-HTPNot stated
AshwagandhaNot stated
Alpha GPCNot stated
Bacopa monnieriNot stated
Rhodiola roseaNot stated
PiperineNot stated

The manufacturer does not state the amount of any ingredient. Without amounts, the research summarised in this guide cannot be related to this product's dose.

Scientific background

Independent research

Noopept (omberacetam)

Noopept (N-phenylacetyl-L-prolylglycine ethyl ester, omberacetam) is a synthetic compound described as an active pharmaceutical ingredient with nootropic activity1.

Phenylpiracetam (fonturacetam)

Phenylpiracetam (fonturacetam) is a racetam drug related to piracetam, used as a prescription medicine in Russia.

DMHA (2-aminoisoheptane, octodrine) and DMBA

DMHA, also labelled 2-aminoisoheptane or octodrine (2-amino-6-methylheptane), is a synthetic aliphatic amine stimulant found in pre-workout and weight-loss supplements, sometimes alongside the related compound DMBA2.

5-HTP (5-hydroxytryptophan)

5-HTP is the direct precursor of the neurotransmitter serotonin and is usually extracted from Griffonia simplicifolia seeds3.

Ashwagandha (Withania somnifera)

Ashwagandha (Withania somnifera) is an Ayurvedic herb marketed as an adaptogen; extracts are standardised to withanolides.

Choline (choline bitartrate, alpha-GPC)

Choline is an essential nutrient used to make cell membranes and the neurotransmitter acetylcholine. EFSA set an adequate intake of 400 mg a day for adults4. Supplements supply it as choline bitartrate, alpha-GPC or citicoline.

Bacopa monnieri (brahmi)

Bacopa monnieri (brahmi) is an Ayurvedic herb whose extracts contain bacosides.

Rhodiola rosea

Rhodiola rosea is a plant from cold regions whose root extract (standardised to rosavins and salidroside) is marketed as an adaptogen.

Piperine (black pepper extract, BioPerine®)

Piperine is the pungent alkaloid of black pepper, added to supplements as a "bioavailability enhancer".

Research evidence

Independent research

Noopept (omberacetam)

There are no robust controlled trials in healthy people showing improved memory or focus. Published research is mainly chemical, animal or from limited clinical settings1.

Phenylpiracetam (fonturacetam)

There are no robust controlled trials in healthy people showing cognitive benefits.

DMHA (2-aminoisoheptane, octodrine) and DMBA

There are no controlled human trials showing that DMHA improves exercise performance or weight loss.

5-HTP (5-hydroxytryptophan)

A review of controlled trials examined 5-HTP for depression; the evidence is limited and of mixed quality3. There is no authorised EU claim for 5-HTP.

Ashwagandha (Withania somnifera)

A 2026 meta-analysis found that current evidence does not establish that ashwagandha meaningfully enhances resistance-training adaptations; possible benefits for maximal strength rest on a small, low-certainty evidence base5.

Choline (choline bitartrate, alpha-GPC)

The EU authorises claims that choline contributes to normal lipid metabolism, homocysteine metabolism and liver function for foods that are a source of choline6. Claims that choline improves focus or exercise performance are not authorised.

Bacopa monnieri (brahmi)

A 2026 network meta-analysis found that bacopa, particularly at high doses, shows promise as a cognitive enhancer compared with ginkgo in healthy adults, although the lack of direct comparisons limits the strength of the evidence7.

Rhodiola rosea

A 2025 meta-analysis concluded that Rhodiola supplementation can improve endurance performance and related biomarkers, although differences between studies call for cautious interpretation8.

Piperine (black pepper extract, BioPerine®)

A 2026 review of 22 human pharmacokinetic studies found that reports of enhanced nutrient absorption come mainly from manufacturer-affiliated studies, and that independent trials did not confirm enhancement for curcumin or resveratrol at supplement doses9.

Evidence limitations

Independent research

This product does not state all ingredient amounts, so the doses used in research cannot be compared with what one serving provides.

The studies summarised in this guide examined single ingredients. No published study has tested this product or this combination of ingredients.

Noopept (omberacetam)

Evidence in humans is very limited.

Phenylpiracetam (fonturacetam)

Evidence is limited and mostly from Russian clinical literature.

DMHA (2-aminoisoheptane, octodrine) and DMBA

The research concerns detection of these stimulants in supplements, not their effects. Analyses of sports and weight-loss supplements have repeatedly found stimulants that were not declared, or quantities different from the label210.

5-HTP (5-hydroxytryptophan)

Most trials are small and old3.

Ashwagandha (Withania somnifera)

Trials are small, short and often funded by extract manufacturers5.

Choline (choline bitartrate, alpha-GPC)

Evidence on cognitive or performance effects in healthy adults is limited.

Bacopa monnieri (brahmi)

Effects build up over weeks, and studies are small7.

Rhodiola rosea

Studies are heterogeneous in extract and dose8.

Piperine (black pepper extract, BioPerine®)

Piperine raises blood levels of other compounds mainly by inhibiting drug-metabolising enzymes (CYP3A4, CYP2C9) and P-glycoprotein, not by improving absorption9.

Safety & potential risks

Independent research

Noopept (omberacetam)

Human safety data are limited. Official medicines control laboratories in Europe and Australia have found illicit "smart drugs" sold as nootropic products and warn of their dangers11.

Phenylpiracetam (fonturacetam)

Reported effects include insomnia and agitation. Official medicines control laboratories in Europe and Australia have found illicit "smart drugs" sold as nootropic products and warn of their dangers11.

DMHA (2-aminoisoheptane, octodrine) and DMBA

Human safety data are lacking. As a sympathomimetic amine, DMHA may raise heart rate and blood pressure; avoid combining it with other stimulants. Contaminated supplements have caused positive doping tests10.

5-HTP (5-hydroxytryptophan)

Safety concerns include serotonin syndrome when combined with antidepressants or other serotonergic substances, and historical reports of eosinophilia-myalgia syndrome linked to contaminated products3. Do not combine with antidepressants, migraine triptans or tramadol.

Ashwagandha (Withania somnifera)

Case series describe ashwagandha-associated liver injury, which can be severe in people with existing liver disease12. It may also affect thyroid hormones and is not recommended in pregnancy.

Choline (choline bitartrate, alpha-GPC)

High intakes can cause a fishy body odour, sweating and digestive upset.

Bacopa monnieri (brahmi)

It can cause digestive upset and may interact with thyroid and sedative medicines.

Rhodiola rosea

Generally well tolerated; it may interact with antidepressants and blood-pressure or diabetes medicines.

Piperine (black pepper extract, BioPerine®)

Because it inhibits drug-metabolising enzymes, piperine can raise blood levels of prescription medicines, including drugs with a narrow therapeutic index. People taking medication should ask a pharmacist first9.

Regulatory status

GIGACULT product information

Contains a synthetic research compound that is not authorised as food (novel food) or as a medicinal product in the EU. Contains DMHA/DMBA, a synthetic stimulant that is not authorised as a novel food in the EU. No dosing information for human use is provided.

Regulation and sport

Noopept (omberacetam)

Noopept is not authorised as a food or food supplement ingredient in the EU13. Substances with a pharmacological action on the nervous system are regulated as medicinal products in the EU, and Noopept is not an authorised medicine14.

Phenylpiracetam (fonturacetam)

Phenylpiracetam is not authorised as a food or food supplement ingredient in the EU13. Substances with a pharmacological action on the nervous system are regulated as medicinal products in the EU, and Phenylpiracetam is not an authorised medicine14. It is prohibited in competition by the World Anti-Doping Agency as a stimulant15.

DMHA (2-aminoisoheptane, octodrine) and DMBA

DMHA and DMBA are not authorised as novel foods in the EU13. Octodrine and related stimulants are prohibited in competition by the World Anti-Doping Agency1015.

5-HTP (5-hydroxytryptophan)

5-HTP is pharmacologically active; some EU Member States restrict it in food supplements or classify it as medicinal14. No health claim for this ingredient is authorised in the EU6; botanical ingredients are sold under national food-supplement rules16.

Ashwagandha (Withania somnifera)

No health claim for this ingredient is authorised in the EU6; botanical ingredients are sold under national food-supplement rules16.

Choline (choline bitartrate, alpha-GPC)

Choline is a permitted nutrient source in EU food supplements166.

Bacopa monnieri (brahmi)

No health claim for this ingredient is authorised in the EU6; it is sold under national food-supplement rules16.

Rhodiola rosea

No health claim is authorised6.

Piperine (black pepper extract, BioPerine®)

No health claim for this ingredient is authorised in the EU6; botanical ingredients are sold under national food-supplement rules16.

Scientific references

  1. Araj SK, Szeleszczuk Ł, Gubica T, et al. Physicochemical and structural analysis of N-phenylacetyl-L-prolylglycine ethyl ester (Noopept): an active pharmaceutical ingredient with nootropic activity. J Pharm Biomed Anal. 2025;252:116474. PubMed 39298839
  2. Cohen PA, Travis JC, Keizers PHJ, et al. Four experimental stimulants found in sports and weight loss supplements: 2-amino-6-methylheptane (octodrine), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylamylamine (1,3-DMAA) and 1,3-dimethylbutylamine (1,3-DMBA). Clin Toxicol (Phila). 2018;56:421-426. PubMed 29115866
  3. Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther. 2006;109:325-338. PubMed 16023217
  4. EFSA Panel on Dietetic Products, Nutrition and Allergies. Dietary Reference Values for choline. EFSA Journal. 2016;14(8):4484. DOI 10.2903/j.efsa.2016.4484
  5. Lee JC, Heo AS. Adjunctive ashwagandha (Withania somnifera) supplementation and resistance-training adaptations in healthy adults: a systematic review and random-effects meta-analysis. Nutrients. 2026;18. PubMed 42738987
  6. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union. Source
  7. Tiemtad P, Ingkaninan K, Temkitthawon P, et al. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: a systematic review and network meta-analysis. Phytomedicine. 2026;153:157915. PubMed 41678913
  8. Wang X, Yang X, Gao Z, et al. The effect of Rhodiola rosea supplementation on endurance performance and related biomarkers: a systematic review and meta-analysis. Front Nutr. 2025;12:1645346. PubMed 41080184
  9. Kaneko M. Enhancement without a rationale? Black pepper extract (piperine) in dietary supplements and the future of formulation: a perspective from Japan. Front Nutr. 2026;13:1981406. PubMed 42964084
  10. Cohen PA, Travis JC, Vanhee C, et al. Nine prohibited stimulants found in sports and weight loss supplements. Clin Toxicol (Phila). 2021;59:975-981. PubMed 33755516
  11. Vanhee C, Deconinck E, George M, et al. The occurrence of illicit smart drugs or nootropics in Europe and Australia and their associated dangers: results from a market surveillance study by 12 official medicines control laboratories. J Xenobiot. 2025;15:88. PubMed 40558871
  12. Philips CA, Valsan A, Theruvath AH, et al. Ashwagandha-induced liver injury: a case series from India and literature review. Hepatol Commun. 2023;7. PubMed 37756041
  13. Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
  14. Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
  15. World Anti-Doping Agency. The Prohibited List (current edition). Source
  16. Directive 2002/46/EC on the approximation of the laws of the Member States relating to food supplements. Official Journal of the European Union. Source

Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product

Revange Nutrition Happy Bee 60 caps

€49,90

View product